Oncotelic Therapeutics Reports FY 2025 Results Highlighting $249M Net Income and JV Pipeline Progress

Go back to Oncotelic Therapeutics Reports FY 2025 Results Highlighting $249M Net Income and JV Pipeline Progress
(AMEX: OTLC) Delayed: 0.05 --0 (-0%)
Previous Close $0.05    52 Week High
Open $0.05    52 Week Low
Day High $0.05    P/E N/A 
Day Low $0.05    EPS
Volume 244,391